Saturday, Apr 17 2021 | Time 05:18 Hrs(IST)
image
  • Ready to meet N Korea's leader Kim Jong Un, says Japanese Prime Minister
  • Argentina registers record 29,472 new COVID-19 cases over past 24 hours: Health Ministry
  • US, Japan committed to meeting zero net carbon emissions by 2050: Biden
  • US, Japan both recognize importance of Taiwan straits: Suga
  • Ontario extends stay-at-home order by 2 weeks, introduces checkpoints at borders
  • NASA planning for 'regularly recurring' human moon missions: Senior Executive
  • SpaceX wins contract to build human mission lander for US return to moon: NASA
  • WTO to hold 12th Ministerial Conference in Geneva from Nov 30 to Dec 3
  • Canada's Ontario could see over 30,000 daily cases by early June: Modeling Data
  • Greek Foreign Minister to Meet With Libyan Presidential Council Head on Saturday
  • Pentagon does not rule out possibility of deploying more capabilities for Afghan pullout
  • Civil war likely if intl forces pull back: Afghan Presidential advisor
  • Raul Castro Resigns as Head of Cuban Communist Party - Official Newspaper
  • EU to dedicate $36Bln to Green Energy Transition in Africa – Official
WorldPosted at: Mar 6 2021 6:12PM


US' top infectious disease official commends Russia's Sputnik V COVID-19 vaccine

Washington, Mar 6 (Sputnik) US National Institute of Allergy and Infectious Diseases Director Anthony Fauci said on Saturday that the data from Russian coronavirus vaccine Sputnik V "looked pretty good" to him.
"The data that I've seen from the Sputnik looked pretty good. I don't have as much information of the Chinese, because the Chinese have two or three different vaccines, so I have not followed carefully the relative efficacy of them, but the data that I've seen from the Russian one looks pretty good," Fauci told Greek broadcaster Skai.
Asked about the side effects of vaccines under use in the United States — by Pfizer and Moderna — Fauci said the level of his concerns was "minimal." According to the official, both mRNA vaccines demonstrated from 94 percent - 95 percent efficacy in US trials while "the reactogenicity was minimum."
Please log in to get detailed story.
Tags: #US' top infectious disease official commends Russia's Sputnik V COVID-19 vaccine
More News

Argentina registers record 29,472 new COVID-19 cases over past 24 hours: Health Ministry

17 Apr 2021 | 4:50 AM

Buenos Aires, Apr 17 (UNI) Argentina has registered 29,472 new COVID-19 cases within the past 24 hours, marking the largest daily increase since the start of the outbreak, the national Ministry of Health said.

see more..

US, Japan committed to meeting zero net carbon emissions by 2050: Biden

17 Apr 2021 | 4:33 AM

Washington, Apr 17 (UNI) The United States and Japan are committed to meeting the zero net carbon emissions goal by 2050, but will first set and achieve other goals by 2030, President Joe Biden said during a press briefing.

see more..

SpaceX wins contract to build human mission lander for US return to moon: NASA

17 Apr 2021 | 2:28 AM

Washington, Apr 16 (UNI) The National Aeronautics and Space Administration (NASA) has chosen Elon Musk's company SpaceX to build the Human Landing System (HLS) for the first US manned mission to the Moon in half a century, HLS contracting officer Lisa Watson-Morgan told a podcast press conference on Friday.

see more..

WTO to hold 12th Ministerial Conference in Geneva from Nov 30 to Dec 3

17 Apr 2021 | 1:42 AM

Moscow, Apr 16 (UNI) The 12th Ministerial Conference of the World Trade Organization (WTO) will take place in Geneva from November 30 to December 3, the WTO press service said on Friday.

see more..

Canada's Ontario could see over 30,000 daily cases by early June: Modeling Data

17 Apr 2021 | 1:30 AM

Toronto, Apr 16 (UNI) The Canadian province of Ontario could see a near seven-fold rise in daily COVID-19 case counts by June if the province implements “weak” public health measures and continues with a subdued vaccine rollout, new data from an expert panel advising the provincial government revealed on Friday.

see more..
image